This document describes the formulation and evaluation of immediate release salbutamol tablets using different proportions of crospovidone as a disintegrating agent. Three formulations were developed with crospovidone levels of 40 mg, 30 mg, and 20 mg. The tablets were evaluated for physical properties, disintegration time, dissolution, and drug content. Formulation 1 with 40 mg crospovidone showed the fastest disintegration time of 2.5 minutes and highest drug release. Further studies are recommended to assess bioavailability in human volunteers and long-term stability testing.